Technical / White Paper

Microsampling in Early Phase Drug Development

Format: PDF file | Document type: Technical / White Paper | Promoted Content

This content is provided by Altasciences, and any views and opinions expressed do not necessarily reflect those of

Microsampling in Early Phase Drug Development

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic drugs, metabolites, and biomarkers in preclinical and clinical research. In preclinical research, microsampling technology supports the 3Rs of animal research, and allows for less intrusive blood collection procedures. This document is intended to analyze the impact and considerations for a successful microsampling approach.

Related resources from Altasciences

Supplier info centre